Peptide receptor radionuclide therapy as neoadjuvant treatment in pancreatic neuroendocrine tumours

被引：0
|
作者：
Prospero, I. [1 ]
Ferreira, G. [1 ]
Ferro, J. C. [1 ]
Barbosa, D. [1 ]
Silva, D. G. [1 ]
Fontao de Castro, S. [1 ]
Teixeira, J. P. [1 ]
Duarte, H. [1 ]
Lucena Sampaio, I. [1 ]
机构：
[1] Inst Portugues Oncol Porto, Porto, Portugal
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2023年 / 50卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-473
引用
收藏
页码：S220 / S220
页数：1
相关论文
共 50 条
  • [41] Treatment of Gastroenteropancreatic Neuroendocrine Tumors with Peptide Receptor Radionuclide Therapy
    van Vliet, Esther I.
    Teunissen, Jaap J. M.
    Kam, Boen L. R.
    de Jong, Marion
    Krenning, Eric P.
    Kwekkeboom, Dik J.
    NEUROENDOCRINOLOGY, 2013, 97 (01) : 74 - 85
  • [42] Targeted Alpha Particle Therapy for Neuroendocrine Tumours: The Next Generation of Peptide Receptor Radionuclide Therapy
    Navalkissoor, Shaunak
    Grossman, Ashley
    NEUROENDOCRINOLOGY, 2019, 108 (03) : 256 - 264
  • [43] Dose response of pancreatic neuroendocrine tumours treated with peptide receptor radionuclide therapy using 177Lu-DOTATATE
    Ilan, E.
    Sandstrom, M.
    Garske-Roman, U.
    Sundin, A.
    Wassberg, C.
    Lubberink, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S223 - S224
  • [44] Peptide Receptor Radionuclide Therapy (PRRT) as neoadjuvant therapy in neuroendocrine tumors - one center experience
    Opalinska, M.
    Sowa-Staszczak, A.
    Grochowska, A.
    Zwinczewska, H.
    Hubalewska-Dydejczyk, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S334 - S334
  • [45] Lutetium-177 Dotatate peptide receptor radionuclide therapy outcomes for neuroendocrine tumours
    AlHilali, M.
    Carberry, J.
    Challis, A.
    Atherton, P.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1095 - S1096
  • [46] Peptide Receptor Radionuclide Therapy In Broncopulmonary Neuroendocrine Tumours - Results Of A Single Centre Experience
    Ferreira, G.
    Castro, S.
    Costa, C.
    Violante, L.
    Teixeira, J.
    Duarte, H.
    Sampaio, I. L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S89 - S89
  • [47] MANAGEMENT OF RESIDUAL PAEDIATRIC PANCREATIC NEUROENDOCRINE TUMOUR WITH PEPTIDE RECEPTOR RADIONUCLIDE THERAPY
    Luthra, Tanvi
    Jain, Vishesh
    Dhua, Anjan
    Jana, Manisha
    Kandasamy, Devasenathipathy
    Kumar, Rakesh
    Shamim, Shamim
    Bal, C. S.
    Iyer, Venkateswaran
    Agarwala, Sandeep
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S64 - S65
  • [48] Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy
    Bodei, Lisa
    Schoeder, Heiko
    Baum, Richard P.
    Herrmann, Ken
    Strosberg, Jonathan
    Caplin, Martyn
    Oeberg, Kjell
    Modlin, Irvin M.
    LANCET ONCOLOGY, 2020, 21 (09): : E431 - E443
  • [49] Predicting the outcome of Peptide Receptor Radionuclide Therapy (PRRT) for the treatment of neuroendocrine tumours using PET-CT
    Houghton, K.
    Carroll, M. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S235 - S236
  • [50] Treatment of neuroendocrine tumours with 177Lu-peptide receptor radionuclide therapy: Challenging clinical scenarios and their management
    Navalkissoor, Shaunak
    Toumpanakis, Christos
    Caplin, Martyn
    Gnanasegaran, Gopinath
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 (04)
12345